Evaluation of elabela, apelin and nitric oxide findings in maternal blood of normal pregnant women, pregnant women with pre-eclampsia, severe pre-eclampsia and umbilical arteries and venules of newborns

References

• Artas G, Ozturk S, Kuloglu T, Dagli AF, Gonen M, Artas H, et al. 2018. A novel candidate molecule in pathological grading of gliomas: ELABELA. Turkish Neurosurgery, 28:989–994.
   Web of Science ®Google Scholar
• Aydin S, Eren MN, Sahin I, Aydin S. 2014. The role of apelins in the physiology of the heart. Protein and Peptide Letters 21:2–9.
   PubMed Web of Science ®Google Scholar
• Aydin S. 2015. A short history, principles, and types of ELISA, and our laboratory experience with peptide/protein analyses using ELISA. Peptides 72:4–15.
   PubMed Web of Science ®Google Scholar
• Bolad I, Delafontaine P. 2005. Endothelial dysfunction: its role in hypertensive coronary disease. Current Opinion in Cardiology 20:270–274.
   PubMed Web of Science ®Google Scholar
• Bortoff KD, Qiu C, Runyon S, Williams MA, Maitra R. 2012. Decreased maternal plasma apelin concentrations in preeclampsia. Hypertension in Pregnancy 31:398–404.
   PubMed Web of Science ®Google Scholar
• Chen K, Pittman RN, Popel AS. 2008. Nitric oxide in the vasculature: where does it come from and where does it go? A quantitative perspective. Antioxidants & Redox Signaling 10:1185–1198.
   PubMed Web of Science ®Google Scholar
• Chng SC, Ho L, Tian J, Reversade B. 2013. ELABELA: a hormone essential for heart development signals via the apelin receptor. Developmental Cell 27:672–680.
   PubMed Web of Science ®Google Scholar
• Choi JW, Im MW, Pai SH. 2002. Nitric oxide production increases during normal pregnancy and decreases in preeclampsia. Annals of Clinical and Laboratory Science 32:257–263.
   PubMed Web of Science ®Google Scholar
• Cobellis L, De Falco M, Mastrogiacomo A, Giraldi D, Dattilo D, Scaffa C, et al. 2007. Modulation of apelin and APJ receptor in normal and preeclampsia-complicated placentas. Histology and Histopathology 22:1–8.
   PubMed Web of Science ®Google Scholar
• Dacaj R, Izetbegovic S, Stojkanovic G, Dreshaj S. 2016. Elevated liver enzymes in cases of preeclampsia and intrauterine growth restriction. Medical Archives (Sarajevo, Bosnia and Herzegovina) 70:44–47.
   PubMedGoogle Scholar
• Dekker GA, Sibai BM. 1998. Etiology and pathogenesis of preeclampsia: current concepts. American Journal of Obstetrics and Gynecology 179:1359–1375.
   PubMed Web of Science ®Google Scholar
• Duckitt K, Harrington D. 2005. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ (Clinical Research Ed.) 330:565.
   PubMed Web of Science ®Google Scholar
• Guzel SP. 2004. Investigation of umbilical artery, leptin and zinc levels of newborns in pathological and normal pregnancies [Specialization Thesis]. Firat University.
   Google Scholar
• Ho L, van Dijk M, Chye STJ, Messerschmidt DM, Chng SC, Ong S, et al. 2017. ELABELA deficiency promotes preeclampsia and cardiovascular malformations in mice. Science (New York, NY) 357:707–713.
   Google Scholar
• Inuzuka H, Nishizawa H, Inagaki A, Suzuki M, Ota S, Miyamura H, et al. 2013. Decreased expression of apelin in placentas from severe pre-eclampsia patients. Hypertension in Pregnancy 32:410–421.
   PubMed Web of Science ®Google Scholar
• Japp AG, Cruden NL, Barnes G, van Gemeren N, Mathews J, Adamson J, et al. 2010. Acute cardiovascular effects of apelin in humans: potential role in patients with chronic heart failure. Circulation 121:1818–1827.
   PubMed Web of Science ®Google Scholar
• Kucur M, Tuten A, Oncul M, Acikgoz AS, Yuksel MA, Imamoglu M, et al. 2014. Maternal serum apelin and YKL-40 levels in early and late-onset pre-eclampsia. Hypertension in Pregnancy 33:467–475.
   PubMed Web of Science ®Google Scholar
• Liakos CI, Sanidas EA, Perrea DN, Grassos CA, Chantziara V, Viniou NA, et al. 2016. Apelin and visfatin plasma levels in healthy individuals with high normal blood pressure. American Journal of Hypertension 29:549–552.
   PubMed Web of Science ®Google Scholar
• Lozano R, Wang H, Foreman KJ, Rajaratnam JK, Naghavi M, Marcus JR, et al. 2011. Progress towards millennium development goals 4 and 5 on maternal and child mortality: an updated systematic analysis. Lancet (London, England) 378:1139–1165.
   PubMed Web of Science ®Google Scholar
• Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P, Canadian Hypertensive Disorders of Pregnancy Working Group. 2014. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. Journal of Obstetrics and Gynaecology Canada 36:416–441.
   PubMedGoogle Scholar
• Matijevic R, Meekins JW, Walkinshaw SA, Neilson JP, McFadyen IR. 1995. Spiral artery blood flow in the central and peripheral areas of the placental bed in the second trimester. Obstetrics and Gynecology 86:289–292.
   PubMed Web of Science ®Google Scholar
• Mughal A, O'Rourke ST. 2018. Vascular effects of apelin: mechanisms and therapeutic potential. Pharmacology & Therapeutics, 190:139–147.
   PubMed Web of Science ®Google Scholar
• Munazza B, Raza N, Naureen A, Khan SA, Fatima F, Ayub M, et al. 2011. Liver function tests in preeclampsia. Journal of Ayub Medical College, Abbottabad: JAMC 23:3–5.
   PubMedGoogle Scholar
• Oyston CJ, Stanley JL, Baker PN. 2015. Potential targets for the treatment of preeclampsia. Expert Opinion on Therapeutic Targets 19:1517–1530.
   PubMed Web of Science ®Google Scholar
• Pritchard N, Kaitu'u-Lino TJ, Gong S, Dopierala J, Smith GCS, Charnock-Jones DS, et al. 2018. ELABELA/APELA levels are not decreased in the maternal circulation or placenta among women with preeclampsia. The American Journal of Pathology, 188:1749–1753.
   PubMed Web of Science ®Google Scholar
• Ranta V, Viinikka L, Halmesmäki E, Ylikorkala O. 1999. Nitric oxide production with preeclampsia. Obstetrics and Gynecology 93:442–445.
   PubMed Web of Science ®Google Scholar
• Say L, Chou D, Gemmill A, Tunçalp Ö, Moller AB, Daniels J, et al. 2014. Global causes of maternal death: a WHO systematic analysis. The Lancet Global Health 2:e323–e333.
   PubMed Web of Science ®Google Scholar
• Soubhi Kahhale S, Francisco RPV, Zugaib M. 2018. Endothelial mechanisms in preeclampsia. Endothelium and cardiovascular diseases, vascular biology and clinical syndromes. p. 655–666. Cambridge: Academic Press.
   Google Scholar
• Szymonowicz W, Yu VY. 1987. Severe pre-eclampsia and infants of very low birth weight. Archives of Disease in Childhood 62:712–716.
   PubMed Web of Science ®Google Scholar
• Wang Z, Yu D, Wang M, Wang Q, Kouznetsova J, Yang R, et al. 2015. Elabela-apelin receptor signaling pathway is functional in mammalian systems. Scientific Reports 5:8170.
   PubMed Web of Science ®Google Scholar
• Xiong X, Demianczuk NN, Saunders LD, Wang FL, Fraser WD. 2002. Impact of preeclampsia and gestational hypertension on birth weight by gestational age. American Journal of Epidemiology 155:203–209.
   PubMed Web of Science ®Google Scholar
• Yang P, Read C, Kuc RE, Buonincontri G, Southwood M, Torella R, et al. 2017. Elabela/toddler is an endogenous agonist of the apelin APJ receptor in the adult cardiovascular system, and exogenous administration of the peptide compensates for the downregulation of its expression in pulmonary arterial hypertension. Circulation 135:1160–1173.
   PubMed Web of Science ®Google Scholar
• Yeganeh-Hajahmadi M, Najafipour H, Rostamzadeh F. 2017. The differential effects of low and high doses of apelin through opioid receptors on the blood pressure of rats with renovascular hypertension. Hypertension Research 40:732–737.
   PubMed Web of Science ®Google Scholar
• Zhao Q, Hixson JE, Rao DC, Gu D, Jaquish CE, Rice T, et al. 2010. Genetic variants in the apelin system and blood pressure responses to dietary sodium interventions: a family-based association study. Journal of Hypertension 28:756–763.
   PubMed Web of Science ®Google Scholar